ClariVest Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$673K	Hold	57,096	–	–	0.07%	324
2024 Q2	$673K	Buy	57,096 +1,535	+3%	+$18.1K	0.07%	324
2024 Q1	$659K	Buy	+55,561	New	+$659K	0.07%	337